Skip to content

Effectiveness and Implementation of Home-Based Motor Relearning for Social Participation After Stroke: A Type II Hybrid Stepped-Wedge Cluster Randomized Trial

Effectiveness and Implementation of Home-Based Motor Relearning for Social Participation After Stroke: A Type II Hybrid Stepped-Wedge Cluster Randomized Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071597
Enrollment
Unknown
Registered
2023-05-18
Start date
2024-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

MRA group:Remote "Motor Relearning" rehabilitation program

Sponsors

School of Nursing, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years with a first-ever ischemic or hemorrhagic stroke, confirmed by CT/MRI, and presenting with a single subcortical lesion involving the motor pathway; 2. Screened within 1–3 weeks after stroke onset and clinically stable; 3. With moderate functional deficits (Brunnstrom stage II–V, National Institutes of Health Stroke Scale (NIHSS) score 2–20, Barthel Index >= 45) (Kwah and Diong, 2014; Mahoney and Barthel, 1965; Shah et al., 1986); 4. Able to stand independently, with sufficient lower limb strength and task execution capacity to engage in motor relearning; and 5. Not enrolled in structured rehabilitation at baseline but with evident rehabilitation needs and adequate family support. 6. The patients and their families were fully informed of the study details, consented to participate, and signed the informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Impaired consciousness, cognitive dysfunction, or psychiatric disorders; 2. Cerebellar or pontine lesions; 3. Musculoskeletal injuries or visual deficits affecting participation; 4. Use of medications that may interfere with motor assessments (e.g., antipsychotics, antiepileptics); 5. Concurrent participation in other clinical trials; 6. Discharge to non-home destinations.

Design outcomes

Primary

MeasureTime frame
Social Participation;

Secondary

MeasureTime frame
Functional Independence;Exercise Adherence;Social Support;Depression;

Countries

China

Contacts

Public ContactQi Zhang

School of Nursing, Sun Yat-Sen University

zhangq569@mail.sysu.edu.cn+86 20 8733 4771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 6, 2026